Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A

Human Molecular Genetics

Volumn 10, Issue 10, 2001, Pages 1007-1018

  Perea, Javier ^a,e   Robertson, Andrea ^b   Tolmachova, Tanya ^a   Muddle, John ^b   King, R H M ^b   Ponsford, S ^d   Thomas, P K ^c   Huxley, Clare ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^e UNIVERSITÉ D EVRY VAL D ESSONNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN PROTEIN; PERIPHERAL MYELIN PROTEIN 22; TETRACYCLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMYELINATION; GENE DUPLICATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HEREDITARY MOTOR SENSORY NEUROPATHY; MOUSE; MYELIN SHEATH; MYELINATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL NERVE; PRIORITY JOURNAL; SCHWANN CELL; SENSITIVITY AND SPECIFICITY; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS; RODENTIA;

EID: 0035339043     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/10.10.1007     Document Type: Article

References (40)

1. Lupski, J.R., Montes de Oca-Luna, R., Slaugenhaupt, S., Pentao, L., Guzzetta, V., Trask, B.J., Saucedo-Cardenas, O., Barker, D.F., Killian, J.M., Garcia, CA. et al. (1991) DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell, 66, 219-232.
2. Raeymaekers, P., Timmerman, V., Nelis, E., De Jonghe, P., Hoogendijk, J.E., Baas, F., Barker, D.F., Martin, J.-J., De Visser, M., Bolhuis, P.A. and Van Broeckhoven, C. (1991) Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group. Neuromusc. Disord., 1, 93-97.
3. Suter, U., Moskow, J.J., Welcher, A.A., Snipes, G.J., Kosaras, B., Sidman, R.L., Buchberg, A.M. and Shooter, E.M. (1992) A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse. Proc. Natl Acad. Sci. USA, 89, 4382-4386.
4. Wise, C.A., Garcia, C.A., Davis, S.N., Heju, Z., Pentao, L., Patel, P.I. and Lupski, J.R. (1993) Molecular analyses of unrelated Charcot-Marie-Tooth (CMT) disease patients suggest a high frequency of the CMT1A duplication. Am. J. Hum Genet., 53, 853-863.
5. Nelis, E., Van Broeckhoven, C., De Jonghe, P., Lofgren, A., Vandenberghe, A., Latour, P., Le Guem, E., Brice, A., Mostacciuolo, M.L., Schiavon, F. et al. (1996) Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur. J Hum. Genet., 4, 25-33.
6. Gabreels-Festen, A.A.W.M., Bolhuis, P.A., Hoogendijk, J.E., Valentijn, L.J., Eshuis, E.J.H.M. and Gabreëls, F.J.M. (1995) Charcot-Marie-Tooth disease type 1A: morphological phenotype of the 17p duplication versus PMP22 point mutations. Acta Neuropathol., 90, 645-649.
7. Snipes, G.J. and Suter, U. (1995) Molecular anatomy and genetics of myelin proteins in the peripheral nervous system. J. Anal., 186, 483-494.
8. D'Urso, D., Ehrhardt, P. and Muller, H.W. (1999) Peripheral myelin protein 22 and protein zero: a novel association in peripheral nervous system myelin. J. Neurosci., 19, 3396-3403.
9. Fabbreti, E., Edomi, P., Brancolini, C. and Schneider, C. (1995) Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A. Genes Dev., 9, 1846-1856.
10. Zoidl, G., Blass-Kampmann, S., D'Urso, D., Schmalenbach, C. and Müller, H.W. (1995) Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: modulation of cell growth. EMBO J., 14, 1122-1128.
11. Naef, R., Adlkofer, K., Lescher, B. and Suter, U. (1997) Aberrant protein trafficking in Trembler suggests a disease mechanism for hereditary human peripheral neuropathies. Mol. Cell. Neurosci., 9, 13-25.
12. D'Urso, D., Prior, R., Greiner-Petter, R., Gabreëls-Festen, A.A.W.M. and Müller, H.W. (1998) Overloaded endoplasmic reticulum-golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22. J. Neurosci., 18, 731-740.
13. Brancolini, C., Edomi, P., Marzinotto, S. and Schneider, C. (2000) Exposure at the cell surface is required for Gas3/PMP22 to regulate both cell death and cell spreading: implication for the Charcot-Marie-Tooth Type IA and Dejerine-Sotlas diseases. Mol. Biol. Cell, 11, 2901-2914.
14. Huxley, C., Passage. E., Manson, A., Putzu, G., Figarella-Branger, D., Pellissier, J.F. and Fontés, M. (1996) Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum. Mol. Genet., 5, 563-569.
15. Magyar, J.P., Martini, R., Ruelicke, T., Aguzzi, A., Adlkofer, K., Dembic, Z., Zielasek, J., Toyka, K.V. and Suter, U. (1996) Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J. Neurosci., 16, 5351-5360.
16. Sereda, M., Griffiths, I., Pühlhofer, A., Stewart, H., Rossner, M.J., Zimmermann, F., Magyar, J.P., Schneider. A., Hund, E., Meinck, H.-M. et al. (1996) A transgenic rat model of Charcot-Marie-Tooth disease. Neuron. 16, 1049-1060.
17. Huxley, C., Passage, E., Robertson, A.M., Youl, B., Huston, S., Manson, A., Sabéran-Djoniedi, D., Figarella-Branger, D., Pellissier, J.F., Thomas, P.K. and Fontés, M. (1998) Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum. MoL. Genet., 7, 449-458.
18. Gossen, M. and Bujard, H. (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl Acad. Sci. USA, 89, 5547-5551.
19. Furth, P.A., St Onge, L., Böger, G., Gruss, P., Gossen, M., Kistner, A., Bujard, H. and Hennighausen, L. (1994) Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc. Natl Acad. Sci. USA, 91, 9302-9306.
20. Madrid, R. and Bradley, W.G. (1975) The pathology of neuropathies with focal thickening of the myelin sheath (Tomaculous neuropathy). Studies on the formation of the abnormal myelin sheath. J. Neurol. Sci., 25, 415-448.
21. Shockett, P., Difilippantonio, M., Hellman, N. and Schatz, D.G. (1995) A modified tetracylcine-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc. Natl Acad. Sci. USA, 92, 6522-6526.
22. Maycox, P.R., Ortuño, D., Burrola, P., Kuhn, R., Bieri, P.L., Arrezo, J.C. and Lemke, G. (1997) A transgenic mouse model for human hereditary neuropathy with liability to pressure palsies. Mol. Cell. Neurosci., 8, 405-416.
23. Adlkofer, K., Martini, R., Aguzzi, A., Zielasek, J., Toyka, K.V. and Suter, U. (1995) Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat. Genet., 11, 274-280.
24. Chance, P.F., Alderson, M.K., Leppig, K.A., Lensch, M.W., Matsunami, N., Smith, B., Swanson, P.D., Odelberg, S.J., Disteche, C.M. and Bird, T.D. (1993) DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell, 72, 143-151.
25. Hildebrand, C., Bowe, C.M. and Remahl, I.N. (1994) Myelination and myelin sheath remodelling in normal and pathological PNS nerve fibres. Prog. Neurobiol., 43, 85-141.
26. De Leon, M., Nahin, R.L., Mendoza, M.E. and Ruda, M.A. (1994) SR13/ PMP-22 expression in rat nervous system, in PC12 cells, and C6 glial cell lines. J. Neurosci. Res., 38, 167-181.
27. Parmantier, E., Cabon, F., Braun, C., D'Urso, D., Müller, H.W. and Zalc, B. (1995) Peripheral myelin prolein-22 is expressed in rat and mouse brain and spinal cord motoneurons. Eur. J. Neurosci., 7, 1080-1088.
28. Suter, U., Snipes, G.J., Schoener-Scott, R., Welcher, A.A., Pareek, S., Lupski, J.R., Murphy, R.A., Shooter, E.M. and Patel, P.I. (1994) Regulation of tissue-specific expression of alternative peripheral myelin Protein-22 (PMP22) gene transcripts by two promoters. J. Biol. Chem., 269, 25795-25808.
29. van de Wetering, R.A.C., Gabreëls-Festen, A.A.W.M., Kremer, H., Kalscheuer, V.M., Gabreëls, F.J.M. and Mariman, B.C. (1999) Regulation and expression of the murine Pmp22 gene. Mamm. Genome, 10, 419-422.
30. Dobie, K., Mehtali, M., McClenaghan, M. and Lathe, R. (1997) Variegated gene expression in mice. Trends Genet., 13, 127-130.
31. Ballin, R.H.M. and Thomas, P.K. (1969) Electron microscope observations on demyelination and remyelination in experimental allergic neuritis. J. Neurol. Sci., 8, 225-237.
32. Jacobs, J.M. and Cavanagh, J.B. (1969) Species differences in internode formation following two types of peripheral nerve injury. J. Anal., 105, 295-306.
33. Niemann, S., Sereda, M.W., Suter, U., Griffiths, I.R. and Nave, K.-A. (2000) Uncoupling of myelin assembly and Schwann cell differentiation by transgenic overexpression of peripheral myelin protein 22. J. Neurosci., 20, 4120-4128.
34. Aguayo, A.J., Attiwell, M., Trecarten, J., Perkins, S. and Bray, G.M. (1977) Abnormal myelination in transplanted Trembler mouse Schwann cells. Nature, 265, 73-75.
35. Davison, A.N. (1961) Metabolically inert proteins of the central and peripheral nervous system, muscle and tendon. Biochem. J., 78, 272-282.
36. Gould, R.M. (1977) Incorporation of glycoproteins into peripheral nerve myelin. J. Cell Biol., 75, 326-338.
37. Tolmachova, T., Simpson, K. and Huxley, C. (1999) Analysis of a YAC with human telomeres and oriP from Epstein-Barr virus in yeast and 293 cells. Nucleic Acids Res., 27, 3736-3744.
38. Burgers, P.M.J. and Percival, K.J. (1987) Transformation of yeast spheroplasts without cell fusion. Anal. Biochem., 163, 391-397.
39. Gnirke, A., Huxley, C., Peterson, K. and Olson, M.V. (1993) Microinjection of intact 200-to 500-kb fragments of YAC DNA into mammalian cells. Genomics, 15, 659-667.
40. Hogan, B., Costantini, F. and Lacy, E. (1986) Manipulating the Mouse Embryo. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.